Back
LYFE SCIENCES
Project: HERA
NM_007294.4:c.4450T>G
p.Ser1484Ala  ·  BRCA1
Starting
Initialising…
0%
Legacy Engine
Processing…
Classification rationale
1

NM_007294.4:c.4450T>G (p.Ser1484Ala) is a missense variant in BRCA1 exon 13, located outside all ENIGMA-defined clinically important functional domains (between the coiled-coil domain at aa 1391-1424 and the BRCT domain at aa 1650-1857).

cspec ↗
2

The variant is absent from gnomAD v2.1 and v4.1 population databases (PM2_Supporting). However, read depth at this position should be confirmed via gnomAD screenshots to ensure the absence is not artifactual.

gnomad_v2 ↗ gnomad_v4 ↗
3

BP1_Strong is met: the variant is a missense substitution outside all three BRCA1 clinically important functional domains, and SpliceAI predicts no splicing impact (max delta = 0.03).

spliceai ↗ cspec ↗
4

No functional assay data (PS3/BS3) are available for p.Ser1484Ala in ENIGMA calibrated assays. The only codon-1484 variant with functional data is c.4450T>A (p.Ser1484Thr, BS3_Strong), but this evidence does not transfer to the Ala substitution.

5

ClinVar reports this variant as Uncertain Significance (3 clinical laboratories, criteria provided, single submitter). No expert panel classification is available.

clinvar ↗
6

No co-segregation (PP1/BS4), case-control (PS4), or clinical-history likelihood ratio (PP4/BP5) data are available for this variant.

7

Applying ENIGMA v1.2.0 Table 3 combining rules: the criteria evidence yields BP1_Strong (1 Strong Benign) + PM2_Supporting (1 Supporting Pathogenic). With one Strong Benign and one Supporting Pathogenic, the evidence is conflicting. Per ENIGMA Table 3, neither the benign nor the likely benign combination thresholds are met: a single Strong Benign criterion alone is insufficient for Likely Benign without an accompanying Supporting Benign or Moderate Benign. The classification remains Uncertain Significance (VUS).

cspec ↗
Applied criteria
Met
Not met
Not assessed
N/A
Very strong
Strong
Moderate
Supporting
Pathogenic evidence
PVS
PVS1
PS
PS1
PS2
PS3
PS4
PM
PM1
PM2
PM3
PM4
PM5
PM6
PP
PP1
PP2
PP3
PP4
PP5
Benign evidence
BA
BA1
BS
BS1
BS2
BS3
BS4
BP
BP1
BP2
BP3
BP4
BP5
BP6
BP7
PVS1
Rationale
Select a criterion to inspect its explanation.
Evidence used
Gaps remaining
Rule
Publications
Research and evidence
ClinVar evidence
02
ClinVar
This variant has been reported in ClinVar as Uncertain significance (3 clinical laboratories). (ClinVarID = 630099)
Functional evidence
03
Functional
OncoKB: Unknown Oncogenic Effect
OncoKB did not identify variant-specific reviewed functional evidence for this variant; gene-level curated context is available for reviewer follow-up. BRCA1, a tumor suppressor involved in the DNA damage response, is mutated in various cancer types.
In silico evidence
04
In silico
SpliceAI predicts no significant splice impact for this variant (max delta score = 0.03). REVEL score = 0.15. BayesDel score = -0.314566.
COSMIC evidence
05
COSMIC
This variant does not lie in a statistically significant hotspot. This variant has not previously been reported in somatic cancers (COSMIC).
Cancer hotspots evidence
06
Cancer hotspots Not found
This variant does not lie in a statistically significant hotspot.